Rheumatic And Autoimmune Diseases

Although data supporting cannabis use in patients with rheumatic diseases “continue to grow,” most of the recent literature have been reviews rather than primary research, according to a review published in Current Rheumatology Reports.

The news that the Supreme Court may overturn Roe v. Wade sent a shockwave through all corners of the United States.

Impacting roughly 1 million to 4 million Americans, Sjögren’s syndrome is estimated to be one of the most common autoimmune diseases in the United States, according to the Sjögren’s Foundation.

March is Autoimmune Awareness Month, and rheumatology organizations have been using their reach and influence on social media sites to spread the word and help patients with autoimmune diseases find community.

Autoimmune treatments accounted for more than half of all specialty drug growth in 2021, according to a drug trend report released by CVS Health.

Growing up, I had an aunt with rheumatoid arthritis. In those days, there were few effective treatments. By the time she was in her 40s, she was confined to a wheelchair. She died at age 54 from complications of the disease. This was in the 1960s, and there was little that doctors could do for her.

Just 0.7% of fully vaccinated patients with inflammatory rheumatic and musculoskeletal disease experience a breakthrough COVID-19 infection, while only 4.4% demonstrate disease flare reactions, according to data.

Few randomized clinical trials support using repository corticotropin injection for most FDA-approved indications, including rheumatoid arthritis, ankylosing spondylitis, lupus, optic neuritis and nephrotic syndrome, according to researchers.

Significant knowledge and research gaps are making it difficult to provide evidence-based recommendations on induced abortion to patients with rheumatic disease, according to a review article published in Arthritis Care & Research.

DMARD interruptions in patients with autoimmune rheumatic diseases increased more than 80% between December 2020 and May 2021, leading to higher rates of self-reported flares, according to data published in Arthritis Care & Research.